Physician profile
Thomas C Malvar
NPI 1528089083
$9,610.65
in general payments reported to CMS, 2019-2025
23 companies · $511 in 2025
The $511 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,081 · 2020: $108 · 2021: $788 · 2022: $480 · 2023: $240 · 2024: $402 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,153.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,804.86 | 2019 | |
| Abbvie INC. | $693.81 | 2019-2024 | |
| Teleflex LLC | $387.10 | 2021-2025 | Barrigel |
| Astellas Pharma US INC | $343.50 | 2019-2024 | Myrbetriq, Xtandi |
| Olympus America INC. | $285.05 | 2021-2025 | Soltive, Soltive |
| Myovant Sciences INC. | $198.23 | 2021-2022 | |
| Boston Scientific Corporation | $189.47 | 2019-2025 | Rezum Generator, Advance Xp, Axonics |
| Janssen Biotech, INC. | $89.42 | 2023-2024 | Erleada |
| Tolmar, INC. | $74.66 | 2023-2025 | Eligard, Jatenzo |
| Axonics, INC. | $71.59 | 2021-2024 | Axonics |
| Medtronic, INC. | $70.07 | 2021-2024 | Interstim |
| Antares Pharma, INC. | $69.37 | 2021-2023 | Tlando, Xyosted, Nocdurna |
| Sumitomo Pharma America, INC. | $65.78 | 2023-2025 | Orgovyx, Gemtesa |
| Urovant Sciences INC | $60.31 | 2022 | |
| Neotract INC. | $37.73 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $32.40 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $29.27 | 2022-2023 | Myrisk |
| Agiliti Surgical, INC. | $25.91 | 2025 | Koelis Trinity Mri/US Fusion |
| Profound Medical Corp. | $23.51 | 2025 | Tulsa-Pro |
| Intercept Pharmaceuticals, INC. | $20.23 | 2019 | |
| Angiodynamics, INC. | $18.25 | 2024 | Nanoknife |
| Accord Healthcare, INC. | $17.06 | 2024 | |
| Ambu INC. | $3.07 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Malvar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.